Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.23 USD | +3.15% | -14.99% | -59.59% |
16/04 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.67M 222M |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.75B | Net income 2025 * | -29M -2.42B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.3
x | P/E ratio 2025 * |
-0.44
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.34% |
Latest transcript on Windtree Therapeutics, Inc.
1 day | +3.15% | ||
1 week | -14.99% | ||
Current month | -17.92% | ||
1 month | -17.85% | ||
3 months | -32.43% | ||
6 months | -71.51% | ||
Current year | -59.59% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/16/01 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/20/09 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/21/03 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/23/22 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/21/03 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 5.23 | +3.15% | 28,473 |
25/24/25 | 5.07 | -1.65% | 12,491 |
24/24/24 | 5.155 | -9.30% | 51,395 |
23/24/23 | 5.683 | +4.28% | 81,950 |
22/24/22 | 5.45 | -11.42% | 197,945 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.59% | 2.67M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- WINT Stock